Literature DB >> 23080348

Comparative perioperative outcomes associated with neuraxial versus general anesthesia for simultaneous bilateral total knee arthroplasty.

Ottokar Stundner1, Ya-Lin Chiu, Xuming Sun, Madhu Mazumdar, Peter Fleischut, Lazaros Poultsides, Peter Gerner, Gerhard Fritsch, Stavros G Memtsoudis.   

Abstract

BACKGROUND AND OBJECTIVES: The influence of the type of anesthesia on perioperative outcomes after bilateral total knee arthroplasty (BTKA) remains unknown. Therefore, we examined a large sample of BTKA recipients, hypothesizing that neuraxial anesthesia would favorably impact on outcomes.
METHODS: We identified patient entries indicating elective BTKA between 2006 and 2010 in a national database; subgrouped them by type of anesthesia: general (G), neuraxial (N), or combined neuraxial-general (NG); and analyzed differences in demographics and perioperative outcomes.
RESULTS: Of 15,687 identified procedures, 6.8% (n = 1066) were performed under N, 80.1% (n = 12,567) under G, and 13.1% (n = 2054) under NG. Comparing N to G and NG, patients in group N were, on average, younger (63.9, 64.6, and 64.8 years; P = 0.030) but did not differ in overall comorbidity burden. Patients in group N required blood product transfusions significantly less frequently (28.5%, 44.7%, 38.0%; P < 0.0001). In-hospital mortality, 30-day mortality, and complication rates tended to be lower in group N, without reaching statistical significance. After adjusting for covariates, N and NG were associated with 16.0% and 6.0% reduction in major complications compared with G, but only the reduced odds for the requirement of blood transfusions associated with N reached statistical significance (N vs G: odds ratio, 0.52 [95% CI, 0.45-0.61], P < 0.0001; NG vs G: odds ratio, 0.77 [95% CI, 0.69-0.86], P < 0.0001).
CONCLUSIONS: Neuraxial anesthesia for BTKA is associated with significantly lower rates of blood transfusions and, by trend, decreased morbidity. Although by itself the effect may be limited, N might be used within a multimodal approach to reduce complications after BTKA.

Entities:  

Mesh:

Year:  2012        PMID: 23080348      PMCID: PMC3653590          DOI: 10.1097/AAP.0b013e31826e1494

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  25 in total

Review 1.  Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials.

Authors:  A Rodgers; N Walker; S Schug; A McKee; H Kehlet; A van Zundert; D Sage; M Futter; G Saville; T Clark; S MacMahon
Journal:  BMJ       Date:  2000-12-16

2.  Thirty-day mortality after total knee arthroplasty.

Authors:  J Parvizi; T A Sullivan; R T Trousdale; D G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2001-08       Impact factor: 5.284

Review 3.  The effects of local anesthetics on perioperative coagulation, inflammation, and microcirculation.

Authors:  Klaus Hahnenkamp; Gregor Theilmeier; Hugo K Van Aken; Christian W Hoenemann
Journal:  Anesth Analg       Date:  2002-06       Impact factor: 5.108

4.  Bilateral total knee arthroplasty: risk factors for major morbidity and mortality.

Authors:  Stavros G Memtsoudis; Yan Ma; Ya-Lin Chiu; Lazaros Poultsides; Alejandro Gonzalez Della Valle; Madhu Mazumdar
Journal:  Anesth Analg       Date:  2011-07-13       Impact factor: 5.108

5.  Polysaccharide hemostatic system reduces blood loss in high-body-mass-index patients undergoing simultaneous bilateral total knee arthroplasty.

Authors:  Erdem Aktas; Ali Volkan Kaya; Mehmet Ali Deveci; Kenan Ozler; Halil Akdeniz; Hasan Yildirim
Journal:  J Orthop Sci       Date:  2012-04-05       Impact factor: 1.601

6.  A comparison of neuraxial block versus general anesthesia for elective total hip replacement: a meta-analysis.

Authors:  William J Mauermann; Ashley M Shilling; Zhiyi Zuo
Journal:  Anesth Analg       Date:  2006-10       Impact factor: 5.108

7.  Steroid modulation of cytokine release and desmosine levels in bilateral total knee replacement: a prospective, double-blind, randomized controlled trial.

Authors:  Kethy M Jules- Elysee; Sarah E Wilfred; Stavros G Memtsoudis; David H Kim; Jacques T YaDeau; Michael K Urban; Michael L Lichardi; Alexander S McLawhorn; Thomas P Sculco
Journal:  J Bone Joint Surg Am       Date:  2012-12-05       Impact factor: 5.284

8.  Comparison of general and spinal anesthesia and their influence on hemostatic markers in patients undergoing total hip arthroplasty.

Authors:  Sabine Brueckner; Ulrike Reinke; Angela Roth-Isigkeit; Sawas Eleftheriadis; Peter Schmucker; Hans-Joachim G Siemens
Journal:  J Clin Anesth       Date:  2003-09       Impact factor: 9.452

9.  Prevention of thromboembolic disease following total knee arthroplasty. Epidural versus general anesthesia.

Authors:  D Mitchell; R J Friedman; J D Baker; J E Cooke; M D Darcy; M C Miller
Journal:  Clin Orthop Relat Res       Date:  1991-08       Impact factor: 4.176

10.  Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement.

Authors:  Yasir J Sepah; Masood Umer; Tashfeen Ahmad; Faria Nasim; Muhammad Umer Chaudhry; Muhammad Umar
Journal:  J Orthop Surg Res       Date:  2011-05-21       Impact factor: 2.359

View more
  22 in total

1.  Neuraxial anesthesia decreases postoperative systemic infection risk compared with general anesthesia in knee arthroplasty.

Authors:  Jiabin Liu; Chenjuan Ma; Nabil Elkassabany; Lee A Fleisher; Mark D Neuman
Journal:  Anesth Analg       Date:  2013-09-10       Impact factor: 5.108

2.  Provider Board Certification Status and Practice Patterns in Total Knee Arthroplasty.

Authors:  Peter M Fleischut; Jonathan M Eskreis-Winkler; Licia K Gaber-Baylis; Gregory P Giambrone; Xian Wu; Xuming Sun; Cynthia A Lien; Susan L Faggiani; Richard P Dutton; Stavros G Memtsoudis
Journal:  Acad Med       Date:  2016-01       Impact factor: 6.893

3.  Variability in anesthetic care for total knee arthroplasty: an analysis from the anesthesia quality institute.

Authors:  Peter M Fleischut; Jonathan M Eskreis-Winkler; Licia K Gaber-Baylis; Gregory P Giambrone; Susan L Faggiani; Richard P Dutton; Stavros G Memtsoudis
Journal:  Am J Med Qual       Date:  2014-03-13       Impact factor: 1.852

4.  The impact of sleep apnea on postoperative utilization of resources and adverse outcomes.

Authors:  Stavros G Memtsoudis; Ottokar Stundner; Rehana Rasul; Ya-Lin Chiu; Xuming Sun; Satya-Krishna Ramachandran; Roop Kaw; Peter Fleischut; Madhu Mazumdar
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

5.  Blood Transfusions May Have Limited Effect on Muscle Oxygenation After Total Knee Arthroplasty.

Authors:  Stavros G Memtsoudis; Thomas Danninger; Ottokar Stundner; Daniel Yoo; Federico P Girardi; Friedrich Boettner; Isabelle Kao; Kara G Fields; Michael K Urban; Stephen O Heard; J Matthias Walz
Journal:  HSS J       Date:  2015-03-07

Review 6.  Anesthetic and Analgesic Management for Outpatient Knee Arthroplasty.

Authors:  Chris Cullom; Jonathan T Weed
Journal:  Curr Pain Headache Rep       Date:  2017-05

Review 7.  Preoperative cardiac risk assessment for noncardiac surgery in patients with heart failure.

Authors:  Jenica Upshaw; Michael S Kiernan
Journal:  Curr Heart Fail Rep       Date:  2013-06

8.  Perioperative comparative effectiveness of anesthetic technique in orthopedic patients.

Authors:  Stavros G Memtsoudis; Xuming Sun; Ya-Lin Chiu; Ottokar Stundner; Spencer S Liu; Samprit Banerjee; Madhu Mazumdar; Nigel E Sharrock
Journal:  Anesthesiology       Date:  2013-05       Impact factor: 7.892

9.  Effects of Systemic Disorders on Postoperative Complications After Simultaneous Bilateral Total Knee Replacement.

Authors:  Tünay Kandemir; Selda Muslu; Dilek Kalaycı; Erbin Kandemir
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-02-16

10.  Sleep apnoea adversely affects the outcome in patients who undergo posterior lumbar fusion: a population-based study.

Authors:  O Stundner; Y-L Chiu; X Sun; S-K Ramachandran; P Gerner; V Vougioukas; M Mazumdar; S G Memtsoudis
Journal:  Bone Joint J       Date:  2014-02       Impact factor: 5.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.